Study of Liberty Program on Women's Health and Intimate Partner Violence

Violence Against Women Clinical Trial

Official title:

Study of Liberty Program on Women's Health and Intimate Partner Violence: Multinational, Open, Randomised, Controlled Clinical Study

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT02437201
• Other study ID #: Mac/NMP 1121
• Status: Active, not recruiting
• Phase: N/A
• First received: May 3, 2015
• Last updated: September 27, 2015
• Start date: July 2015
• Est. completion date: December 2017

Study information

• Verified date: September 2015
• Source: Macmillan Research Group UK
• Contact: n/a
• Is FDA regulated: No
• Health authority: India: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

Previous studies indicated high frequency of abuse in families and its consequences. Considering the importance of interventions such as educational interventions, in order to increase women's abilities to prevent abusive behaviors, the current research aims to determine the impact of an Liberty program on prevention of violence against women and propose solutions for less damages and consequences.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 500
• Est. completion date: December 2017
• Est. primary completion date: June 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• Be married,

• Be under the aegis of Foundation at least for a year,

• Have at least one child.

Exclusion Criteria:

• Not participating in two educational sessions,

• Not being interested in continuing the cooperation.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

• Violence Against Women

Intervention

Behavioral:
• Liberty Program

Locations

Country	Name	City	State
Australia	Liberty Australia	Melbourne
China	Liberty China	Shanghai	Shanghai
Greece	Liberty Europe	Athens
India	Vinita Nursing Home	Hindaun	Rajasthan
India	Sonal Foundation	Mahesana	Gujarat
Pakistan	Liberty Pakistan	Lahore	Punjaab
South Africa	Liberty Africa	Johannesburg
United States	Liberty USA	Boston	Massachusetts

Sponsors (4)

Lead Sponsor	Collaborator
Macmillan Research Group UK	Goldington Family Center, UK, Sonal Foundation, India, Vinita Nursing Home, India

Countries where clinical trial is conducted

United States,  Australia,  China,  Greece,  India,  Pakistan,  South Africa, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Quality of Life measured by SF 36 Scale		Change from baseline in SF 36 Scale at 6 months	No
Secondary	Self-Esteem measured by Rosenberg Self-Esteem Questionnaire		Change from Baseline in Rosenberg Self-Esteem Questionnaire at 6 months	No